
New Blood Test Monitors Myeloma Without Invasive Procedures
Cancer patients with multiple myeloma can now track their treatment progress with a simple blood draw instead of painful bone marrow biopsies. This breakthrough makes monitoring minimal residual disease faster, easier, and less painful for thousands of patients.

















